Catalyst Pharmaceuticals Inc CPRX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 10:43 AM EDT
5.07quote price arrow down-0.12 (-2.41%)
Volume
110,317
52 week range
2.88 - 6.24
Loading...
  • Open5.15
  • Day High5.15
  • Day Low5.05
  • Prev Close5.19
  • 52 Week High6.24
  • 52 Week High Date08/13/21
  • 52 Week Low2.88
  • 52 Week Low Date11/02/20

Key Stats

  • Market Cap521.59M
  • Shares Out102.98M
  • 10 Day Average Volume0.77M
  • Dividend-
  • Dividend Yield-
  • Beta1.36
  • YTD % Change52.1

KEY STATS

  • Open5.15
  • Day High5.15
  • Day Low5.05
  • Prev Close5.19
  • 52 Week High6.24
  • 52 Week High Date08/13/21
  • 52 Week Low2.88
  • 52 Week Low Date11/02/20
  • Market Cap521.59M
  • Shares Out102.98M
  • 10 Day Average Volume0.77M
  • Dividend-
  • Dividend Yield-
  • Beta1.36
  • YTD % Change52.1

RATIOS/PROFITABILITY

  • EPS (TTM)0.70
  • P/E (TTM)7.23
  • Fwd P/E (NTM)9.29
  • EBITDA (MRQ)46.138M
  • ROE (MRQ)49.72%
  • Revenue (MRQ)126.90M
  • Gross Margin (MRQ)85.84%
  • Net Margin (MRQ)58.80%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/08/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Catalyst Pharmaceuticals Inc

There is no recent news for this security.

Profile

MORE
Catalyst Pharmaceuticals, Inc. is a commercial-stage, patient-centric biopharmaceutical company. The Company is focused on in-licensing, developing, and commercializing medicines for patients living with rare diseases. The Company is developing a pipeline of medicines for other rare diseases. The Company's product Firdapse Tablet, 10 mg, is used for the treatment of adults with Lambert-Eaton Myasthenic Syndrome (LEMS) patients (ages 17 and above) in the United States and...
Patrick McEnany
Chairman
Steven Miller Ph.D.
Chief Operating Officer
Alicia Grande CPA
Chief Financial Officer
Mary Coleman
Vice President
Address
355 ALHAMBRA CIRCLE, SUITE 801
Coral Gables, FL
33134
United States

Top Peers

SYMBOLLASTCHG%CHG
ATNX
Athenex Inc
3.19-0.08-2.59%
RIGL
Rigel Pharmaceuticals Inc
3.67-0.10-2.78%
KPTI
Karyopharm Therapeutics Inc
6.20-0.32-4.91%
CARA
Cara Therapeutics Inc
15.57-0.47-2.93%
CLVS
Clovis Oncology Inc
4.82-0.05-1.13%